159 related articles for article (PubMed ID: 19371030)
21. Chlorofullerene C60Cl6: a precursor for straightforward preparation of highly water-soluble polycarboxylic fullerene derivatives active against HIV.
Troshina OA; Troshin PA; Peregudov AS; Kozlovskiy VI; Balzarini J; Lyubovskaya RN
Org Biomol Chem; 2007 Sep; 5(17):2783-91. PubMed ID: 17700846
[TBL] [Abstract][Full Text] [Related]
22. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
Klon AE; Glick M; Davies JW
J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
[TBL] [Abstract][Full Text] [Related]
23. Prediction and analysis of binding affinities for chemically diverse HIV-1 PR inhibitors by the modified SAFE_p approach.
Arenas M; Villaverde MC; Sussman F
J Comput Chem; 2009 Jun; 30(8):1229-40. PubMed ID: 18988271
[TBL] [Abstract][Full Text] [Related]
24. Fullerene-based inhibitors of HIV-1 protease.
Strom TA; Durdagi S; Ersoz SS; Salmas RE; Supuran CT; Barron AR
J Pept Sci; 2015 Dec; 21(12):862-70. PubMed ID: 26767741
[TBL] [Abstract][Full Text] [Related]
25. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models.
Steindl TM; Schuster D; Laggner C; Chuang K; Hoffmann RD; Langer T
J Chem Inf Model; 2007; 47(2):563-71. PubMed ID: 17381173
[TBL] [Abstract][Full Text] [Related]
26. Improvement of protein-compound docking scores by using amino-acid sequence similarities of proteins.
Fukunishi Y; Nakamura H
J Chem Inf Model; 2008 Jan; 48(1):148-56. PubMed ID: 18166019
[TBL] [Abstract][Full Text] [Related]
27. Low-throughput model design of protein folding inhibitors.
Broglia RA; Tiana G; Sutto L; Provasi D; Perelli V
Proteins; 2007 May; 67(2):469-78. PubMed ID: 17295323
[TBL] [Abstract][Full Text] [Related]
28. TGSA-Flex: Extending the capabilities of the Topo-Geometrical Superposition Algorithm to handle flexible molecules.
Gironés X; Carbó-Dorca R
J Comput Chem; 2004 Jan; 25(2):153-9. PubMed ID: 14648614
[TBL] [Abstract][Full Text] [Related]
29. A simple quick route to fullerene amino acid derivatives.
Strom TA; Barron AR
Chem Commun (Camb); 2010 Jul; 46(26):4764-6. PubMed ID: 20517578
[TBL] [Abstract][Full Text] [Related]
30. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes.
Rezácová P; Pokorná J; Brynda J; Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezác J; Grantz Sasková K; Sieglová I; Plesek J; Sícha V; Grüner B; Oberwinkler H; Sedlácek' J; Kräusslich HG; Hobza P; Král V; Konvalinka J
J Med Chem; 2009 Nov; 52(22):7132-41. PubMed ID: 19874035
[TBL] [Abstract][Full Text] [Related]
31. Computational proteomics analysis of binding mechanisms and molecular signatures of the HIV-1 protease drugs.
Verkhivker G
Artif Intell Med; 2009; 45(2-3):197-206. PubMed ID: 18926674
[TBL] [Abstract][Full Text] [Related]
32. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
Li D; Liu MS; Ji B; Hwang K; Huang Y
J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
[TBL] [Abstract][Full Text] [Related]
33. Iodo-controlled selective formation of pyrrolidino[60]fullerene and aziridino[60]fullerene from the reaction between C6) and amino acid esters.
Zhang X; Gan L; Huang S; Shi Y
J Org Chem; 2004 Aug; 69(17):5800-2. PubMed ID: 15307764
[TBL] [Abstract][Full Text] [Related]
34. In silico approaches: prediction of biological targets for fullerene derivatives.
Gupta SK; Dhawan A; Shanker R
J Biomed Nanotechnol; 2011 Feb; 7(1):91-2. PubMed ID: 21485819
[TBL] [Abstract][Full Text] [Related]
35. Fullerene derivative as anti-HIV protease inhibitor: molecular modeling and QSAR approaches.
Ibrahim M; Saleh NA; Elshemey WM; Elsayed AA
Mini Rev Med Chem; 2012 Jun; 12(6):447-51. PubMed ID: 22587761
[TBL] [Abstract][Full Text] [Related]
36. Fullerene-based amino acids and peptides.
Bianco A; Da Ros T; Prato M; Toniolo C
J Pept Sci; 2001 Apr; 7(4):208-19. PubMed ID: 11354464
[TBL] [Abstract][Full Text] [Related]
37. Triad and cyclic diad compounds of [60]fullerene with metallocenes.
Mancel D; Jevric M; Davies ES; Schröder M; Khlobystov AN
Dalton Trans; 2013 Apr; 42(14):5056-67. PubMed ID: 23396573
[TBL] [Abstract][Full Text] [Related]
38. Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid.
Tanimoto S; Sakai S; Matsumura S; Takahashi D; Toshima K
Chem Commun (Camb); 2008 Nov; (44):5767-9. PubMed ID: 19009075
[TBL] [Abstract][Full Text] [Related]
39. Flexible side chain models improve enrichment rates in in silico screening.
Kokh DB; Wenzel W
J Med Chem; 2008 Oct; 51(19):5919-31. PubMed ID: 18771256
[TBL] [Abstract][Full Text] [Related]
40. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin.
Rouse JG; Yang J; Ryman-Rasmussen JP; Barron AR; Monteiro-Riviere NA
Nano Lett; 2007 Jan; 7(1):155-60. PubMed ID: 17212456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
